| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.019 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |